After adjustment using propensity scores , the primary end point of clinically relevant bleeding events ( defined as the composite of Bleeding Academic Research Consortium , BARC , type 3 , 4 or 5 bleeding ) at 1year , occurred at a similar rate in both patient groups ( prasugrel/clopidogrel : 3.8 % / 5.5 % ) .